U.S. Ebola Response Highlights WHO Shortcomings

The United States’ independent scramble to contain Ebola has laid bare the constraints of a solo strategy.

U.S. Ebola response reveals WHO gaps

Analysts note that the federal effort poured ↑ $1.2B into field hospitals, yet infection rates fell ↓ 30% across West Africa. Without coordinated data sharing, the mission risked duplication and delayed vaccine rollout, a concern echoed by Reuters.

“The episode proves that unilateral action cannot replace multilateral oversight,” said a senior epidemiologist.

As the world watches, the episode may force a recalibration of the WHO’s authority and funding mechanisms.

Words by Dr. Silas Mercer (Biotech & Longevity Editor).